21:16:42 EST Fri 22 Feb 2019
Enter Symbol
or Name

Helius Medical Technologies Inc (2)
Symbol C : HSM
Shares Issued 26,872,120
Close 2018-07-12 C$ 12.46
Recent Sedar Documents

Helius appoints Laux chief commercialization officer

2018-07-12 17:21 ET - News Release

Mr. Philippe Deschamps reports


Helius Medical Technologies Inc. has appointed Jennifer Laux as chief commercialization officer, effective July 9, 2018.

"We are delighted to have someone with Jennifer's exceptional skills and experience in this role," said Helius's chief executive officer, Philippe Deschamps. "Her experience growing commercial organizations and bringing global products to market will be invaluable as Helius enters its next stage of growth."

"I'm thrilled to join the Helius team, as we prepare to commercialize the company's innovative PoNS [portable neuromodulation stimulator] technology, for the treatment of chronic balance disorders associated with mild to moderate traumatic brain injury," said Ms. Laux. "Helius is positioning itself to serve this large, high unmet needs market and continues to develop its innovative technology with the goal of addressing the symptoms of other neurological diseases or trauma."

Ms. Laux brings extensive experience in leading successful global commercialization strategies and new product launches. Prior to joining Helius, Ms. Laux was vice-president at Inovio Pharmaceuticals Inc., where she headed commercial, launch and new product strategy and was instrumental in prioritizing the portfolio of commercial assets and developing the go-to-market strategy for the company's lead asset. Before joining Inovio, Ms. Laux was vice-president of marketing at Boehringer Ingelheim, where she directed strategy execution, brand planning and sales for the company's cardiovascular franchise. Prior to this, Ms. Laux served for 17 years at Merck & Co. Inc., where she held numerous marketing leadership positions in Merck's cardiovascular, oncology, women's health and specialty franchises.

Ms. Laux earned a BA in international studies and English from Georgetown University and an MBA and MA in marketing and international studies from the Wharton School and Joseph H. Lauder Institute at the University of Pennsylvania.

About Helius Medical Technologies Inc.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The company's first product in development is the portable neuromodulation stimulator (PoNS).

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.